Sight Sciences Inc (SGHT) Long-Term Liabilities to Equity
Sight Sciences, Inc. (SGHT) implements minimally invasive methods to combat glaucoma and dry eye by restoring natural fluid drainage. This chart illustrates the asset's price action, where the indicator stands at 0.61. The business relies on the production of affordable, high-margin OMNI plastic microcatheters, pursuing profitability through the expansion of US insurance reimbursements and physician training.
Comprehensive metric breakdowns and analytics for Sight Sciences, Inc. (SGHT)
- market value and analyst target forecast:
- market capitalization details:
- business book valuation details:
- debt and solvency information:
Total Debt to Capital Coefficient Sight Sciences, Inc.|SGHT - Long-Term Debt to Capital|Short-Term Debt to Capital sightsciences.com|SGHT - Company Debts|Debt to Book Capitalization Ratio Sight Sciences|SGHT - Company Long-Term Debts|Short-Term Debt Volume Sight Sciences, Inc.|Critical Liquidity Ratio sightsciences.com
- business earnings and investment ratios data:
Comprehensive company analysis:Sight Sciences Inc.
This indicator measures the proportion of liabilities with a maturity exceeding one year relative to equity, determining the business's financial resilience to external crises. Analyzing the long-term debt-to-net assets ratio allows for an assessment of leverage efficiency, which is critical for Sight Sciences (SGHT) when scaling sales of glaucoma treatment systems and managing legal expenses.
Key competitors
Boston Scientific Corp (BSX) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Edwards Lifesciences Corp (EW)|RMD: Long-Term Liabilities to Equity|Long-Term Debt to Capital PODD (Insulet Corporation)|Zimmer (ZBH) - Long-Term Liabilities to Capital|CooperCompanies - Long-Term Debt to Capital|Invisalign (ALGN) - Long-Term Debt to Equity Ratio|GMED: Long-Term Debt to Capital|TMDX - Ratio of Long-Term Indebtedness to Capital|ATEC (Alphatec Holdings, Inc.) - Long-Term Debt to Capital|Long-Term Debt to Capital artivion.com|Long-Term Debt to Equity Enovis (ENOV)|Long-Term Debt to Equity IART (Integra LifeSciences Corp)|Long-Term Debt to Capital ESTA (Motiva)|Ratio of Long-Term Indebtedness to Capital iLet Bionic Pancreas (BBNX)|IRMD: Long-Term Debt to Equity Ratio|Long-Term Liabilities to Equity EMBC|TNDM: Long-Term Debt to Capital|Long-Term Liabilities to Capital AxoGen Inc (AXGN)|SIBN (SI-BONE Corp) - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio OFIX (Orthofix Corp)|Long-Term Debt to Equity Ratio BVS (Bioventus Inc.)|KIDS (orthopediatrics.com) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Treace Medical Concepts, Inc. TMCI|SRTA - Long-Term Debt to Equity Ratio|Carlsmed Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital RxSight Ophthalmic|CLPT: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio STXS|STIM (Neuronetics) - Long-Term Debt to Capital|Orchestra BioMed Inc. (OBIO) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital ANIK|Long-Term Debt to Equity Ratio InspireMD Inc. NSPR|Long-Term Debt to Capital ZJYL (Jin Medical)|Long-Term Debt to Capital Vivani Medical Inc VANI|XTNT - Long-Term Debt to Equity|NMTC: Long-Term Debt to Equity|MODD (modular-medical.com) - Long-Term Debt to Equity Ratio|Myomo Inc - Long-Term Debt to Capital Coefficient|COCH (Envoy Medical, Inc.) - Long-Term Debt to Capital|Long-Term Liabilities to Capital vivoslife.com VVOS|Long-Term Debt to Equity enVVeno Medical Corp. (NVNO)|sintx.com (SINT) - Long-Term Indebtedness to Equity|Tenon Medical, Inc - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Lifeward Ltd. LFWD|Autonomix - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital invobioscience.com IVF|Bone Biologics Corp (BBLG) - Long-Term Debt to Equity|Long-Term Liabilities to Equity AXNX (Axonics Inc.)|Long-Term Debt to Equity Biolase, Inc.|Long-Term Debt to Equity Ratio Dynatronics Corp. (DYNT)|Long-Term Debt to Capital FNA|INVO - Long-Term Liabilities to Capital